A global health initiative is offering this grant to strengthen Liberia’s public health infrastructure in response to the Ebola virus disease (EVD) crisis. This grant is for the purpose of enhancing healthcare worker protection through comprehensive Infection Prevention Control (IPC) training, especially in Eastern Liberia. Additionally, it will bolster clinical laboratory capabilities for rapid EVD diagnosis, improve specimen transport, and provide essential training for Liberian technicians. A critical focus is on strengthening blood transfusion services, including the collection and storage of convalescent plasma. This approach offers potential life-saving therapy for current and future outbreaks, building a more resilient health system in Liberia against EVD and other infectious diseases.
Opportunity ID: 292933
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | CDC-RFA-GH15-16300301SUPP17 |
| Funding Opportunity Title: | COPY OF Sustained Strengthening of Public Health Laboratory, Transfusion Services, and Health Care Worker Infection Control Practices for Ebola Virus Disease in Liberia |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | 1 |
| Assistance Listings: | 93.318 — Protecting and Improving Health Globally: Building and Strengthening Public Health Impact, Systems, Capacity and Securit |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Mar 31, 2017 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | Apr 27, 2017 Electronically submitted applications must be submitted no later than 5:00 p.m., ET, on the listed application due date. |
| Current Closing Date for Applications: | Apr 27, 2017 Electronically submitted applications must be submitted no later than 5:00 p.m., ET, on the listed application due date. |
| Archive Date: | May 27, 2017 |
| Estimated Total Program Funding: | $20,000,000 |
| Award Ceiling: | $10,000,000 |
| Award Floor: | $0 |
Eligibility
| Eligible Applicants: | Others (see text field entitled “Additional Information on Eligibility” for clarification) |
| Additional Information on Eligibility: | University of Massachusetts Medical School (UMASS), Academic Consortium Combating Ebola in Liberia (ACCEL) |
Additional Information
| Agency Name: | Centers for Disease Control – CGH |
| Description: | Liberia is one of three West African nations most heavily affected by the Ebola virus disease (EVD). During the onset of EVD outbreak in Liberia, many hospitals and clinics were closed. As these facilities reopen it is imperative that Health Care Workers (HCW) remain vigilant to ensure that they are able to appropriately triage suspected EVD patients while protecting themselves from possible exposure. One of the highest risk groups for contracting EVD has been healthcare workers (HCW), with over 360 cases and 170 fatalities reported in this high-risk group in Liberia alone. This award will implement comprehensive Infection Prevention Control (IPC) training, as well as support and monitoring for Health Care Workers in Eastern Liberia. A second component of the award is to prioritize and strengthen clinical laboratory support that will provide more rapid diagnosis for EVD and other common illnesses in hospital laboratories and to support laboratory transport processes to reference laboratories. A major challenge is differentiating the diagnosis of Ebola which has non-specific initial symptoms such fever, vomiting, diarrhea from more common everyday diseases such as malaria, viral illnesses, or complicated pregnancy. Direct PCR testing or a rapid diagnostic within the hospital laboratory setting could play a crucial role in allowing patients with Ebola to be addressed appropriately. Another key component is to geographically align laboratories to maximize testing coverage, enhance transportation of specimens, and facilitate the development of more comprehensive testing, education, and training opportunities for Liberian laboratory technicians. In addition, this is an unparalleled opportunity to strengthen blood transfusion services for the country of Liberia. Convalescent plasma and whole blood have been used extensively for the treatment of Ebola on the basis that antibodies to Ebola virus within the plasma of survivors could confer immunity or partial immunity for the acutely ill EVD patient. While definitive studies have yet to prove the efficacy of convalescent plasma in controlled trials, for patients in the US during this epidemic, convalescent plasma has become an unofficial standard of treatment. Within Liberia, the Bill and Melinda Gates Foundation is currently funding an ongoing clinical trial at ELWA to test the efficacy of convalescent plasma. Improving donor collection and implementing component therapy allowing for the collection and storage of convalescent plasma could provide larger-scale life-saving therapy and potentially prophylaxis during this current outbreak in Liberia, as well as other affect West African nations, and if stored could help in the treatment of future outbreaks in the near-term or long-term. |
| Link to Additional Information: | |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Locola Hayes
EUN1@cdc.gov Email:EUN1@cdc.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 292933 Full Announcement-CDC-RFA-GH15-16300301SUPP17 -> CDC-RFA-GH15-16300301SUPP17.pdf
Packages
| Agency Contact Information: | Locola Hayes EUN1@cdc.gov Email: EUN1@cdc.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| 93.318 | CDC-RFA-GH15-16300301SUPP17 | COPY OF Sustained Strengthening of Public Health Laboratory, Transfusion Services, and Health Care Worker Infection Control Practices for Ebola Virus Disease in Liberia | PKG00231771 | Mar 31, 2017 | Apr 27, 2017 | View |
Package 1
Mandatory forms
292933 SF424_2_1-2.1.pdf
292933 SFLLL_1_2-1.2.pdf
292933 SF424A-1.0.pdf
292933 HHS_CheckList_2_1-2.1.pdf
292933 ProjectNarrativeAttachments_1_2-1.2.pdf
292933 BudgetNarrativeAttachments_1_2-1.2.pdf
Optional forms
292933 OtherNarrativeAttachments_1_2-1.2.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
